Expert roundtable discussion: ccRCC diagnosis using [89Zr]Zr-DFO-girentuximab

Подробнее о видео

In this roundtable discussion on ccRCC diagnosis, specifically using [89Zr]Zr-DFO-girentuximab, Prof. Peter Mulders moderates the conversation with experts Prof. Charles Van Praet and Dr. Irene Hübner-Resch, who present two clinical cases using 89Zr]Zr-DFO-girentuximab. This discussion was recorded at EAU25 in Madrid, Spain.